Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Super-enhancers (SEs) refer to large clusters of enhancers that drive gene expressions. Recent data has provided novel insights in elucidating the roles of SEs in many diseases, including cancer. Many mechanisms involved in tumorigenesis and progression, ranging from internal gene mutation and rearr...
Saved in:
Main Authors: | Yi He (Author), Wenyong Long (Author), Qing Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
by: Zhiyuan Yao, et al.
Published: (2024) -
Targeting CDK12 is a novel therapeutic strategy through disrupting oncogene associated super‐enhancers in metastatic colorectal cancer
by: Zhijian Kuang, et al.
Published: (2022) -
Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy
by: Fuda Xie, et al.
Published: (2022) -
Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
by: Hang Li, et al.
Published: (2022) -
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
by: Zhen-Chu Tang, et al.
Published: (2023)